USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Cambridge Biotech Corp.ora- Ti
City: Worcester
State: MA
Zip+4: 01605
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $107,230.00 3
SBIR Phase II $945,084.00 2

Award List:

PURIFICATION OF HTLV-I RECOMBINANT ENVELOPE ANTIGEN

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00

PURIFICATION OF HTLV-I RECOMBINANT ENVELOPE ANTIGEN

Award Year / Program / Phase: 1989 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $429,624.00
Abstract:
The long term objective of the research initiated by this proposal is to develop an improved diagnostic assay for detection of antibodies to htlv-i in human sera using recombinant dna derived antigens. htlv-i is a human retrovirus that has been shown to cause a form of adult t-cell leukemia, and has… More

RECOMBINANT SUBUNIT VACCINE FOR HUMAN CYTOMEGALOVIRUS

Award Year / Program / Phase: 1991 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kensil, Charlotte A , Principal Investigator
Award Amount: $7,230.00
Abstract:
The long-term objective of this project is the development of an effective vaccine against human cytomegalovirus (cmv). to accomplish this, experimental formulations containing a unique and safe purified saponin adjuvant will be compared to control preparations in saline, in freund's complete… More

RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

Award Year / Program / Phase: 1991 / SBIR / Phase I
Agency: HHS
Principal Investigator: Coughlin, Richard T , Principal Investigator
Award Amount: $50,000.00

RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

Award Year / Program / Phase: 1994 / SBIR / Phase II
Agency: HHS
Principal Investigator: Coughlin, Richard T , Principal Investigator
Award Amount: $515,460.00
Abstract:
The long-term objective is to develop a rapid enzyme linked immunoassay for toxigenic clostridium difficile. c. difficile is the most frequent cause of antibiotic-associated diarrhea and colitis, and the most frequently identified cause of enteric disease in industrialized nations. single treatment… More